'Serious complications' are more frequent in COVID-19 patients given convalescent plasma, study says, dashing hopes for the treatment
A large Canadian-led study has shown, for now, that not only are the antibodies of recovered COVID-19 patients ineffective when used to treat seriously ill patients - but that convalescent plasma can even be harmful in certain circumstances.
The serious complications include an increased risk of intubation. There was also an increased risk of death.
The research involving Ste-Justine Hospital physician Dr. Philippe Begin as a co-principal investigator was published Thursday in the journal Nature Medicine.
Convalescent plasma consists of the antibody-containing liquid portion of a recovered person’s blood. The hypothesis was that once transfused to a sick patient, the antibodies would help the patient’s immune system fight the disease.
When the complete results were analyzed it wasn’t the lack of the treatment’s benefits that surprised investigators since the preliminary results of the CONCOR-1 study were equally underwhelming and prompted trial coordinators to stop recruitment last winter.
But some in the scientific community were taken aback by convalescent plasma’s serious downside - an increased risk for the patients’ health.
“That's what changes everything because according to many, it wasn't even considered possible," Begin said, but “overall, in our study, there were statistically more adverse events in the plasma group than in the non-plasma group.”
As a result, the researchers are urging clinicians to be cautious about using convalescent plasma outside of a research protocol, especially when they don’t have information about the antibody content.
BETTER AND WORSE ANTIBODY PROFILES
The study enrolled 940 patients in 73 hospitals in Canada, the United States, and Brazil for the randomized, controlled study.
Researchers say they were able to demonstrate that the specific antibody profile of the convalescent plasma administered had much to do with the effects on the patients.
According to information released by Ste Justine Hospital, the effect was determined by two distinct functions: the ability to neutralize the virus by interfering with its ability to invade the cell, or the ability to harness the power of the immune system to attack infected cells.
It’s this second function that could explain the negative effect of some plasmas.
"We know that not all antibodies have the same ability to activate the immune system. If dysfunctional antibodies are transfused, they can take the place of the patient's own antibodies against the virus, and ultimately interfere with the natural immune response,” Begin explained in a release.
The worst plasma, Begin said, seems to have a lot of antibodies, but with the wrong function.
Patients who received plasma with an antibody profile described as “good” had a comparable risk of intubation and death to that of the control group.
However, patients who received an “unfavourable’ antibody profile ”had a higher mortality rate,” the hospital reported.
MORE STUDIES NEEDED
While this was Canada’s largest clinical trial on convalescent plasma and COVID-19, and its findings are consistent with other studies, it does not mean that the book is closed, said Begin.
Now that many people have recovered from COVID-19 and have also been doubly vaccinated, “the antibody profile is extremely good for both neutralization and immune activation function," he said.
So Begin said it’s still possible convalescent plasma could hold promise as a treatment, but different antibody profiles will have to be properly evaluated before they know for certain.
CTVNews.ca Top Stories
NDP calls out Conservatives for effort to squash pharmacare legislation
The federal New Democrats are calling out Conservative Leader Pierre Poilievre and his party for trying to block the bill that could pave the way for millions of Canadians to access birth control and diabetes coverage.
Stamp prices rise for the third time in five years amid financial woes for Canada Post
Canada Post is increasing stamp prices for the third time since 2019, a move the Crown corporation says is a "reality" of its sales-based revenue structure.
Winnipeg man admits to killing four women, argues he's not criminally responsible
Defence lawyers of Jeremy Skibicki have admitted in court the accused killed four Indigenous women, but argues he is not criminally responsible for the deaths by way of mental disorder – this latest development has triggered a judge-alone trial rather than a jury trial.
An El Nino-less summer is coming. Here's what that could mean for Canada
As Canadians brace themselves for summer temperatures, forecasters say a weakening El Nino cycle doesn’t mean relief from the heat.
Mediterranean staple may lower your risk of death from dementia, study finds
A daily spoonful of olive oil could lower your risk of dying from dementia, according to a new study by Harvard scientists.
A subset of Alzheimer's cases may be caused by two copies of a single gene, new research shows
For the first time, researchers have identified a genetic form of late-in-life Alzheimer’s disease — in people who inherit two copies of a worrisome gene.
B.C. court date set for 3 accused of murdering Sikh activist Hardeep Singh Nijjar
Three suspects accused of murdering British Columbia Sikh activist Hardeep Singh Nijjar last year are scheduled to appear in court in Surrey on Tuesday.
Ontario MPP asked again to leave Ontario legislature over keffiyeh, Speaker loosens ban
An Ontario MPP was asked again to leave the Ontario legislature on Monday for wearing a keffiyeh, a garment that was banned by the Speaker last month due to its political symbolism.
WATCH Avian flu: Risk to humans grows as outbreaks spread, warns expert
H5N1 or avian flu is decimating wildlife around the world and is now spreading among cattle in the United States, sparking concerns about 'pandemic potential' for humans. Now a health expert is urging Canada to scale up surveillance north of the border.